- FDA-NIH Biomarker Working Group
- Contents of a Biomarker Description
- Diagnostic Biomarker
- Monitoring Biomarker
- Pharmacodynamic/Response Biomarker
- Predictive Biomarker
- Prognostic Biomarker
- Reasonably Likely Surrogate Endpoint
- Safety Biomarker
- Susceptibility/Risk Biomarker
- Understanding Prognostic versus Predictive Biomarkers
- Validated Surrogate Endpoint
- Validation
- Glossary